Related Experiment Video
Updated: May 10, 2026

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
Published on: November 28, 2010
Conditional inactivation of p53 in mouse ovarian surface epithelium does not alter MIS driven Smad2-dominant negative
Suzanne M Quartuccio1, Daniel D Lantvit, Maarten C Bosland
1Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, Chicago, Illinois, United States of America.
Abstract:
Epithelial ovarian cancer is the most lethal gynecological malignancy among US women. The etiology of this disease, although poorly understood, may involve the ovarian surface epithelium or the epithelium of the fallopian tube fimbriae as the progenitor cell. Disruptions in the transforming growth factor beta (TGFβ) pathway and p53 are frequently found in chemotherapy-resistant serous ovarian tumors. Transgenic mice expressing a dominant negative form of Smad2 (Smad2DN), a downstream transcription factor of the TGFβ signaling pathway, targeted to tissues of the reproductive tract were created on a FVB background. These mice developed epithelium-lined inclusion cysts, a potential precursor lesion to ovarian cancer, which morphologically resembled oviductal epithelium but exhibited protein expression more closely resembling the ovarian surface epithelium. An additional genetic "hit" of p53 deletion was predicted to result in ovarian tumors. Tissue specific deletion of p53 in the ovaries and oviducts alone was attempted through intrabursal or intraoviductal injection of Cre-recombinase expressing adenovirus (AdCreGFP) into p53 (flox/flox) mice. Ovarian bursal cysts were detected in some mice 6 months after intrabursal injection. No pathological abnormalities were detected in mice with intraoviductal injections, which may be related to decreased infectivity of the oviductal epithelium with adenovirus as compared to the ovarian surface epithelium. Bitransgenic mice, expressing both the Smad2DN transgene and p53 (flox/flox), were then exposed to AdCreGFP in the bursa and oviductal lumen. These mice did not develop any additional phenotypes. Exposure to AdCreGFP is not an effective methodology for conditional deletion of floxed genes in oviductal epithelium and tissue specific promoters should be employed in future mouse models of the disease. In addition, a novel phenotype was observed in mice with high expression of the Smad2DN transgene as validated through qPCR analysis, characterized by teratoma-like lesions implicating Smad signaling in teratoma development.
Insights
This study investigated ovarian cancer precursors in mice. Disrupting the TGFβ pathway caused cyst formation, a potential early lesion, and high Smad2DN expression led to teratomas.
Area of Science:
- Gynecologic Oncology
- Cancer Etiology
- Translational Research
Background:
- Epithelial ovarian cancer is a lethal gynecological malignancy with poorly understood origins.
- The transforming growth factor beta (TGFβ) pathway and p53 are frequently disrupted in chemotherapy-resistant serous ovarian tumors.
- Ovarian surface epithelium and fallopian tube fimbriae are potential progenitor cells for ovarian cancer.
Purpose of the Study:
- To investigate the role of the TGFβ signaling pathway and p53 in ovarian cancer development using a mouse model.
- To create transgenic mice with disruptions in the TGFβ pathway and p53 to identify potential precursor lesions.
- To evaluate the efficacy of adenovirus-mediated gene deletion in the reproductive tract for future ovarian cancer modeling.
Main Methods:
- Created transgenic mice expressing a dominant-negative Smad2 (Smad2DN) in the reproductive tract.
- Administered Cre-recombinase expressing adenovirus (AdCreGFP) to induce p53 deletion in p53 (flox/flox) mice.
- Analyzed phenotypes including cyst formation, protein expression, and teratoma development via qPCR and morphological assessment.
Main Results:
- Transgenic mice expressing Smad2DN developed epithelium-lined inclusion cysts resembling oviductal epithelium but with ovarian surface epithelium-like protein expression.
- Intrabursal AdCreGFP injection in p53 (flox/flox) mice led to ovarian bursal cysts, while intraoviductal injection did not yield pathological abnormalities.
- Bitransgenic mice (Smad2DN and p53 flox/flox) exposed to AdCreGFP did not develop additional phenotypes, indicating AdCreGFP is ineffective for oviductal epithelium gene deletion.
- High Smad2DN expression correlated with teratoma-like lesions, suggesting a role for Smad signaling in teratoma development.
Conclusions:
- Disruptions in TGFβ signaling can lead to ovarian cyst formation, a potential precursor lesion for ovarian cancer.
- Adenovirus-mediated gene deletion is inefficient in the oviductal epithelium, necessitating alternative strategies like tissue-specific promoters for future models.
- Smad signaling may play a role in the development of teratomas.
More Related Videos
07:44Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice
Published on: February 17, 2023
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Oogenesis